Investigation Report on China Tacrolimus Market, 2010-2019

Tacrolimus (also FK506) is a macrolide lactone immunosuppressive drug discovered from a soil sample that contained the bacterium Streptomyces tsukubaensis in 1984 by Fuji…
Reference: 1506204
Price: $2,000.00
Tax included

General

Publisher:
CRI
Geography Covered
China
Publication Date
6/11/2015
Pages
30
Version:
2010
Charts:
40
Language
  • English
  • Chinese
Format
License

Description

Tacrolimus (also FK506) is a macrolide lactone immunosuppressive drug discovered from a soil sample that contained the bacterium Streptomyces tsukubaensis in 1984 by Fujisawa Pharmaceutical Co., Ltd. Tacrolimus acts like cyclosporine and its systemic use is mainly for the prevention of allograft rejection and the treatment of immune disease. Different from cyclosporine, it can penetrate through epidermis barrier due to its relatively small molecular mass. Therefore to avoid systemic adverse reactions, it can be made into external preparation to treat various immune inflammatory cutaneous disorders.
After entering China in 1999, tacrolimus develops fast with annual sales rising from less than CNY 100 million in 2005 to CNY 688 million in 2014 and CAGR reaching up to 24.7% during this period. Tacrolimus in the Chinese market are in four formulations: injection, capsule, eye drop and ointment, among which the sales value of capsules takes up over 90% of the sum in 2014. Tacrolimus is used for a variety of indications, for example, capsules are mainly used to prevent graft rejection after liver or kidney transplantation.
Tacrolimus in the Chinese market mainly comes from the following companies: Fujisawa Pharmaceutical Co., Ltd (Ireland), Hisun, Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, Sichuan Med-Shine Pharmaceutical Co., Ltd and Astellas Pharma Manufacturing,Inc, among which Fujisawa Pharmaceutical Co., Ltd (Ireland) has the largest market share of 75.40% by sales value in 2014.
As the number of organ transplants and the number of the cases of immune disease increase, the sales value of tacrolimus in China is expected to keep growing.

Readers can get at least the following information from this report:
-market share of manufacturers of tacrolimus in China
-price of tacrolimus in Chinese market
-major manufacturers of tacrolimus in Chinese market
-share of dosage forms of tacrolimus in China
-market outlook of tacrolimus in China

The author suggests the following groups of people purchase this report:
-manufacturers of immunosuppressants
-investors/ research institutions interested in Chinese medicine market
-any interest in the Chinese medicine market, please contact CRI for customized survey service
Table of Contents

1 Related Concepts of Tacrolimus
1.1 Indication
1.2 Developments in Global Market

2 Market Profile of Tacrolimus in China
2.1 Patent and Approval Status of Tacrolimus in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Value of Tacrolimus in China, 2010-2014
3.1 Overall Sales Value
3.2 Sales Value by Regions

4 Survey on Sales Volume of Tacrolimus in China, 2010-2014
4.1 Overall Sales Volume
4.2 Sales Volume by Regions

5 Survey on Market Share of Major Manufacturers of Tacrolimus in China, 2010-2014
5.1 Market Share by Sales Value
5.2 Market Share by Sales Volume

6 Survey on Market Size of Dosage Forms of Tacrolimus in China, 2010-2014
6.1 Market Share of Different Dosage Forms by Sales Value
6.2 Market Share of Different Dosage Forms by Sales Volume

7 Reference Retail Price of Tacrolimus in China in 2014
7.1 Astellas Pharma Manufacturing,Inc.(US) (Trade Name: Prograf)
7.2 Senju Pharmaceutical Co., Ltd (Japan) (Trade Name: Protopic)
7.3 Sichuan Med-Shine Pharmaceutical Co., Ltd (Trade Name: Ming Zhi Xin)
7.4 Sinopharm Chuankang Pharmaceutical Co., Ltd (Trade Name: Yi Li Kang)
7.5 Yamanouchi Pharmaceutical Co., Ltd (Japan)
7.6 Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
7.7 Zhejiang Hisun Pharmaceutical Co.,Ltd.
7.8 Fujisawa Pharmaceutical Co., Ltd (Ireland) (Trade Name: Prograf)

8 Major Manufacturers of Tacrolimus in the Chinese Market, 2010-2014
8.1 Astellas Pharma Manufacturing,Inc.
8.2 Zhejiang Hisun Pharmaceutical Co.,Ltd.
8.3 Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
8.4 Sichuan Med-Shine Pharmaceutical Co., Ltd
8.5 Yamanouchi Pharmaceutical Co., Ltd (Japan)

9 Market Outlook of Tacrolimus in China, 2014-2018
9.1 Forecast of Market Size
9.2 Forecast of Competitive Landscape

Selected Charts
Chart Patent Status of Tacrolimus in China
Chart Approval Information of Tacrolimus in China
Chart Sales Status of Tacrolimus in China, 2010-2014
Chart Sales Value of Tacrolimus in China, 2010-2014
Chart Sales Value of Tacrolimus in Some Regions in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Tacrolimus for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Tacrolimus Made by Fujisawa (Ireland) in China, 2010-2014
Chart Sales Value and Market Share of Tacrolimus Made by Hangzhou Zhongmei Huadong in China, 2010-2014
Chart Sales Value and Market Share of Tacrolimus Made by Yamanouchi (Japan) in China, 2010-2014
Chart Sales Value and Market Share of Tacrolimus Made by Hisun in China, 2010-2014
Chart Sales Value and Market Share of Tacrolimus Injections in China, 2010-2014
Chart Sales Value and Market Share of Tacrolimus Eye Drops in China, 2010-2014
Chart Sales Value and Market Share of Tacrolimus Capsules in China, 2010-2014
Chart Price of Tacrolimus Made by Astellas Pharma Manufacturing,Inc.(US) in Some Regions in China
Chart Price of Tacrolimus Made by Senju Pharmaceutical Co., Ltd (Japan) in Some Regions in China
Chart Price of Tacrolimus Made by Yamanouchi Pharmaceutical Co., Ltd (Japan) in Some Regions in China
Chart Price of Tacrolimus Made by Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd in Some Regions in China
Chart Price of Tacrolimus Made by Hisun in Some Regions in China
Chart Price of Tacrolimus Made by Fujisawa Pharmaceutical Co., Ltd (Ireland) in Some Regions in China
Scroll